TITLE

Refractory Hypotension with ACE Inhibitor Therapy

AUTHOR(S)
Dirito, David L.
PUB. DATE
April 2011
SOURCE
International Student Journal of Nurse Anesthesia;Spring2011, Vol. 10 Issue 1, p20
SOURCE TYPE
Academic Journal
DOC. TYPE
Case Study
ABSTRACT
The article presents a case study of a 68-year-old male with past medical history of diabetes, hyperlipidemia, and hypertension, which was presented for correction of phimosis. It says that the patient was instructed to take lisinopril the morning of surgery but still experienced hypotension in anesthesia. Moreover, it states that hypotension commonly occurs during anesthesia.
ACCESSION #
60162420

 

Related Articles

  • Catecholamine-Resistant Hypotension Following Induction for Spinal Exploration. Trotter, Jason // AANA Journal;Feb2012, Vol. 80 Issue 1, p55 

    Systemic blood pressure is regulated by 3 mechanisms: the sympathetic nervous system, the renin-angiotensin system, and the arginine-vasopressin system. The use of angiotensin II receptor blockers and angiotensin- converting enzyme inhibitors has become prevalent in the medical treatment of...

  • Is the antiproteinuric effect of ACE inhibition mediated by interference in the renin-angiotensin system? Gansevoort, Ron T.; de Zeeuw, Dick; de Jong, Paul E. // Kidney International;Mar1994, Vol. 45 Issue 3, p861 

    Angiotensin convening enzyme (ACE) inhibition causes specific renal effects, such as a rise in effective renal plasma flow, a fall in filtration fraction and a lowering of proteinuria. The mechanism of these renal effects is still debated. Recent animal studies suggest that non-angiotensin (Ang)...

  • Phenylephrine and TRAM Graft Survival. Dieckman, Jim // International Student Journal of Nurse Anesthesia;Summer2011, Vol. 10 Issue 2, p33 

    A positive outcome of breast reconstruction with a pedicled transverse rectus abdominus myocutaneous (TRAM) flap is dependent on the ability of the flap to be perfused during and after surgery. Factors such as temperature, volume status, hematocrit, and blood pressure can affect the perfusion of...

  • Anesthetic care of Roberts syndrome: A Case report. Khandrani, Jitesh; Rajput, Anant; Khan, A.; Nagrale, Manda // Internet Journal of Anesthesiology;2010, Vol. 24 Issue 2, p1 

    Roberts Syndrome is a rare genetic disorder, characterized by multiple systemic involvement. In this report we describe the presentation and management of a case of Roberts syndrome. We report this case of a 4 year old boy who presented with tetraphocomelia, operated cleft lip & palate, mild...

  • Ramipril-based versus diuretic-based antihypertensive primary treatment in patients with pre-diabetes (ADaPT) study.  // Cardiovascular Diabetology;2012, Vol. 11 Issue 1, p1 

    The article focuses on the study conducted to examine the ramipril-based treatment and diuretic-based antihypertensive primary treatment in patients with pre-diabetes (ADaPT). It mentions the study document the first manifestation of type-2 diabetes in both the group. Further it concludes that...

  • Vasopeptidase inhibition: A new treatment approach for endothelial dysfunction. Quaschning, Thomas; Galle, Jan; Wanner, Christoph // Kidney International Supplement;May2003, Issue 84, p54 

    Vasopeptidase inhibition: A new treatment approach for endothelial dysfunction. Angiotensin-converting enzyme (ACE) inhibition is a well-established principle in the treatment of endothelial dysfunction. Numerous preclinical and clinical studies have clearly demonstrated the beneficial effects...

  • Pathophysiology and Management of Angiotensin- Converting Enzyme Inhibitor-Associated Refractory Hypotension During the Perioperative Period. Thoma, Andrea // AANA Journal;Apr2013, Vol. 81 Issue 2, p133 

    Hypertension is a common chronic condition in many patients requiring anesthesia. Pharmacologic therapy is a mainstay of treatment for hypertension, with angiotensin-converting enzyme (ACE) inhibitors being a frequently prescribed class of drugs. The American College of Cardiology and American...

  • Comparative review of the blood pressure-lowering and cardiovascular benefits of telmisartan and perindopril. Ji-Guang Wang; Pimenta, Eduardo; Chwallek, Frank // Vascular Health & Risk Management;2014, Vol. 10, p189 

    Hypertension is a major cardiovascular (CV) risk factor, and blood pressure (BP)-lowering treatment substantially reduces the risk. This review compares the available clinical evidence from the BP-lowering and CV-outcome studies of telmisartan and perindopril, which are among the most...

  • Antiproliferative Efficacy of Angiotensin II Receptor Blockers in Prostate Cancer. Uemura, Hiroji; Nakaigawa, Noboru; Ishiguro, Hitoshi; Kubota, Yoshinobu // Current Cancer Drug Targets;Jul2005, Vol. 5 Issue 5, p307 

    An apparent low prevalence of cancer in hypertensive patients receiving angiotensin converting enzyme inhibitors is reported; however, the molecular mechanisms have not been elucidated. Angiotensin-II (Ang-II) is well known to be associated with hypertension, as a main peptide of the...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics